Beranda › Kanker Rahim
Uji klinis Kanker Rahim yang merekrut di AS
29 studi untuk Kanker Rahim merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX8 studi
- New York City, NY6 studi
- Columbus, OH6 studi
- Boston, MA5 studi
- Philadelphia, PA5 studi
- Miami, FL5 studi
- Austin, TX5 studi
- St. Louis, MO4 studi
- Pittsburgh, PA4 studi
- Nashville, TN4 studi
- Orlando, FL4 studi
- Baltimore, MD4 studi
- Chicago, IL4 studi
- West Palm Beach, FL4 studi
- Providence, RI4 studi
- San Diego, CA3 studi
- Eugene, OR3 studi
- Seattle, WA3 studi
- Minneapolis, MN3 studi
- Arlington, VA3 studi
- Miami Beach, FL3 studi
- Portland, OR3 studi
- Camden, NJ3 studi
- Indianapolis, IN3 studi
- Oklahoma City, OK3 studi
- Birmingham, AL3 studi
- Dallas, TX3 studi
- Fort Worth, TX3 studi
- Cape Coral, FL3 studi
- Baldwin Park, CA3 studi
- St. Petersburg, FL3 studi
Berdasarkan negara bagian
- Alabama3 studi
- Arizona3 studi
- California9 studi
- Florida7 studi
- Georgia3 studi
- Illinois5 studi
- Indiana3 studi
- Maryland5 studi
- Massachusetts5 studi
- Michigan3 studi
- Minnesota5 studi
- Missouri5 studi
- New Jersey6 studi
- New York8 studi
- North Carolina4 studi
- Ohio6 studi
- Oklahoma4 studi
- Oregon4 studi
- Pennsylvania7 studi
- Rhode Island4 studi
- Tennessee4 studi
- Texas10 studi
- Virginia4 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT06952660Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT04038619PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 17 Sep 2026 · NCT05758688Sentinel Node Biopsy in Endometrial Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 15 Sep 2026 · NCT04073706DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Menerima pesertaStudi observasional
Usia 18 hingga 50 · Wanita · Diperbarui 2 Sep 2026 · NCT06904365Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 27 Agu 2026 · NCT06492070PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT04329494Investigations of Reproductive Cancers in Women
Menerima pesertaStudi observasional
Usia 45 hingga 100 · Wanita · Diperbarui 17 Agu 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 13 Agu 2026 · NCT06040970Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366Hypofractionated Radiochemotherapy
Menerima pesertaFase 2
Usia 18 hingga 120 · Wanita · Diperbarui 30 Jul 2026 · NCT06331468Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT07106359[18F]FES PET/.CT in Uterine Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 5 Jun 2026 · NCT05916196Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Menerima peserta
Usia 60 ke atas · Wanita · Diperbarui 29 Mei 2026 · NCT05743517Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 6 Mei 2026 · NCT05049538Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 15 Apr 2026 · NCT05559879Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 24 Mar 2026 · NCT05990426Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Wanita · Diperbarui 6 Mar 2026 · NCT05977621Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 2 Mar 2026 · NCT06369155With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Menerima peserta
Usia 21 ke atas · Wanita · Diperbarui 25 Feb 2026 · NCT05721976Sample Collection for Ongoing Research and Product Evaluation Study
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jan 2026 · NCT07318051Image-Guided Gynecologic Brachytherapy
Menerima peserta
Usia 18 hingga 100 · Wanita · Diperbarui 18 Des 2025 · NCT02993900Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.